AOD-9604 5mg Peptides
Crafted for precision-driven labs, this vial delivers dependable peptide integrity from first reconstitution to final measurement.
Primavora AOD-9604 peptide arrives in a lyophilized research vial (freeze-dried powder) engineered for clean handling and consistent performance. This single-ingredient GH peptide is presented in a lyophilized vial format and provides a total strength of 5mg, offering researchers a focused option for protocol development and analytical work.
- Each vial contains 5mg of AOD-9604 (growth hormone fragment 176-191), a peptide widely explored in metabolic and adipose research settings for its role in lipolysis pathways, receptor signaling, and assay optimization.
Designed for laboratory use, the lyophilized format supports efficient reconstitution and controlled aliquoting. Researchers can expect a clean, particulate-minimized solution when properly handled, enabling accurate dilutions, clear visualization, and reproducible results across sequential experiments. The single-compound profile streamlines method development for chromatography or mass spectrometry workflows and supports in vitro applications where consistency and traceability are essential.
Every Primavora vial is prepared with a disciplined approach to sourcing, synthesis, and packaging. Lots are coded for traceability, and batches are analytically verified to confirm identity and purity using established techniques such as HPLC and mass spectrometry. The lyophilized presentation helps preserve stability during storage and transport, reducing variability and helping protect the integrity of your workbench outcomes.
Primavora is a U.S.-based research supplier committed to exacting standards, careful handling, and transparent quality controls. Our peptides are produced under controlled conditions and batch-tested to help ensure the consistency modern labs require. Clear labeling, dependable specifications, and rigorous documentation reflect our focus on reliability and scientific discipline.
Research Use Only: This material is furnished strictly for laboratory research and development. It is not a drug, food, or cosmetic, and is not intended for human or animal consumption, medical use, or diagnostic applications.
- Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
- Shipping is free on orders of $99+ (except Hawaii and Alaska).
- All orders ship in discreet packaging via USPS Ground Advantage mail.
Delivery restrictions vary by state.
This Product Contains
Customer Reviews
There are no reviews yet. Be the first to write a review!
Frequently Asked Questions
What is AOD-9604?
AOD-9604 is a modified fragment of human growth hormone, commonly described as the 176-191 region. In research settings it is presented as a peptide of interest in lipid-metabolism studies, with a profile intended to differ from full-length growth hormone. It should be framed as a research compound only.
What is AOD-9604 typically studied for?
AOD-9604 is most often studied in relation to fat metabolism, lipolysis, and body-weight regulation in experimental models. It is usually distinguished from full HGH by the fact that researchers investigate it for metabolic effects without assuming the broader growth-promoting actions of native growth hormone.
What are GH peptides?
GH peptides — short for growth-hormone-related peptides — are a research category that includes two main subgroups. The first is growth-hormone-releasing hormone (GHRH) analogs, such as Sermorelin, Tesamorelin, and CJC-1295, which are studied for their interaction with the GHRH receptor. The second is growth hormone secretagogues, such as Ipamorelin, GHRP-2, GHRP-6, and Hexarelin, which are studied for their interaction with the ghrelin receptor (GHS-R1a).
Both subgroups are investigated in the research context of growth-hormone-axis biology. All GH peptide products from Prima Vora are lyophilized research compounds intended solely for in vitro laboratory investigation.
How do GH peptides differ from recombinant growth hormone?
Recombinant human growth hormone is the full 191-amino-acid human GH protein, produced via recombinant DNA technology. It is essentially identical to the endogenous hormone itself. GH peptides, by contrast, are much shorter sequences — typically on the order of a few to a few dozen amino acids — that do not act as GH themselves but rather engage upstream receptors (GHRH-R or GHS-R1a) involved in the GH signaling axis.
This makes the two categories mechanistically distinct. Recombinant GH is a replacement of the hormone itself, while GH peptides are research tools for studying the regulatory machinery that controls endogenous GH release.
What is the difference between GHRH analogs and GH secretagogues?
GHRH analogs are peptides modeled on the natural growth-hormone-releasing hormone sequence. They are studied for their ability to bind the GHRH receptor on the pituitary — the same receptor used by endogenous GHRH. Examples include Sermorelin (a GHRH 1-29 analog), Tesamorelin, and CJC-1295.
GH secretagogues are a structurally different class of peptides that act through the growth hormone secretagogue receptor (GHS-R1a), better known as the ghrelin receptor. Examples include Ipamorelin, GHRP-2, GHRP-6, and Hexarelin. The two classes engage different receptors and are therefore studied as distinct pharmacological families in research on GH signaling.
